Vivani Medical
Vivani Medical

Vivani Medical

Pharmaceuticals
WebsiteInvestor RelationsSEC
Vivani Medical Inc is a preclinical-stage biopharmaceutical company. The company develops miniaturized, subdermal implants utilizing its proprietary NanoPortal technology to enable long-term, near-constant-rate delivery of a broad range of medicines to treat chronic diseases. It has two reporting segments, the Biopharm Division and the Neuromodulation Division. The Biopharm Division includes activities from NPM and Vivani Medical Australia Pty Ltd, and the Neurostimulation Division includes activities from Cortigent and its subsidiary in Switzerland.

$112.8M

Market Cap • 9/28/2026

2003

(23 years)

Founded

2022

(4 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

5,9

P/S

—

P/EBITDA

—

P/OCF

—

P/FCF

—

P/E

—

BVPS

0,3

EPS

—

Market Cap

Market Cap

112,8M

EV

110,7M

EV/Revenue

0

EV/EBITDA

-4,1

EV/EBIT

-4,1

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

-34,6%

Total Yield

-34,6%

Payout

0%

Retained Earnings

-161,7M

Profitability

Gross Margin

—

EBITDA Margin

—

EBIT Margin

—

Net Margin

—

D&A/EBITDA

0%

R&D/Revenue

0%

Capex/Revenue

0%

Capex/D&A

250,8%

Capex/OCF

-4,7%

SBC/OCF

—

% PPE

45,7%

% Goodwill

0%

ROE

—

ROIC

—

Growth

CAGR Op. Income 5Y

27,7%

CAGR Net Income 5Y

26,8%

CAGR EPS 5Y

-17,2%

CAGR OCF 5Y

26,2%

Leverage

N.D./EBITDA

0,1

Debt/Equity

0%

Current Ratio

3,2

Quick Ratio

3,1

Interest Coverage

—

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium